Stockholm, Sweden 2 May 2025
Arex Advisor is delighted to announce the recruitment of Delphine Guérin as our new Business Development Director. Delphine brings a strong track record of driving commercial growth and supporting innovation, with proven expertise in building long term client relationships and navigating complex projects. She holds a PhD in Neuroscience from Université Claude Bernard in Lyon and offers a unique blend of scientific insight and strategic acumen. With her multifaceted experience, she is well equipped to identify market opportunities and shape growth strategies. Prior to joining Arex, Delphine worked as Director of Business Development at SFL Regulatory Affairs & Scientific Communication and Veristat.
“I’m incredibly happy to welcome Delphine to our team as we continue to strengthen our business development capabilities. The life science landscape is evolving at a rapid pace, and as a consultancy, our priority is to remain agile and responsive to industry needs. By expanding our reach and combining expertise across locations, we are able to broaden our high-quality service offering. Delphine’s international experience and personal qualities align perfectly with the global profile of our team, and our vision for future growth and expansion.”
Linda Thunell, CEO
Delphine starts her employment at Arex on 2 May, 2025. She will be based in Basel, Switzerland.
About us: Arex Advisor offers strategic advice and operational support in research and business development for Pharma, Biotech, and Medtech. Our mission is to help leaders and companies realise projects and reach goals. We are passionate about successful processes, from development to commercialisation of important medicines – ultimately contributing to improving the lives of patients.
Contact:
Linda Thunell
contact@arexadvisor.com
